Literature DB >> 657455

Evidence for a splanchnic sodium input monitor regulating renal sodium excretion in man. Lack of dependence upon aldosterone.

R M Carey.   

Abstract

Eight normal male subjects were placed on a constant 10 mEq sodium, 60 mEq potassium diet for 5 days. At 8:00 a.m. on the 5th day, the subjects were given a standard dose of 100 mEq of sodium orally or intravenously. Subjects receiving oral sodium also received 200ml of 5% dextrose in water intravenously, and those receiving intravenous sodium also received placebo capsules orally. Water intake and posture were controlled. The subjects then returned to a free diet for 1 month and subsequently were restudied by using the opposite route of sodium administration. The subjects given the oral sodium load excreted greater quantities of sodium in their urine than those repleted intravenously. The differential natriuresis was significant as early as 2 hours after sodium loading. Plasma aldosterone concentration was similar irrespective of the route of sodium administration. Six patients with primary adrenocortical insufficiency and documented hypoaldosteronism were studied with the same protocol after 5 days of 50 mEq sodium, 60 mEq potassium intake. They also had significantly greater natriuresis after oral than intravenous sodium administration. The data suggest the presence of a splanchnic input monitor for sodium which partially regulates renal sodium excretion and is not dependent upon a turn-off mechanism for aldosterone secretion.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 657455     DOI: 10.1161/01.res.43.1.19

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  19 in total

1.  Gastrin and D1 dopamine receptor interact to induce natriuresis and diuresis.

Authors:  Yue Chen; Laureano D Asico; Shuo Zheng; Van Anthony M Villar; Duofen He; Lin Zhou; Chunyu Zeng; Pedro A Jose
Journal:  Hypertension       Date:  2013-09-09       Impact factor: 10.190

2.  Gastrin induces sodium-hydrogen exchanger 3 phosphorylation and mTOR activation via a phosphoinositide 3-kinase-/protein kinase C-dependent but AKT-independent pathway in renal proximal tubule cells derived from a normotensive male human.

Authors:  Tianbing Liu; Pedro A Jose
Journal:  Endocrinology       Date:  2012-12-28       Impact factor: 4.736

Review 3.  Phosphate sensing.

Authors:  Rajiv Kumar
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-07       Impact factor: 2.894

4.  [Hepato-renal syndrome (author's transl)].

Authors:  J Kipnowski; R Düsing; H J Kramer
Journal:  Klin Wochenschr       Date:  1981-05-04

Review 5.  Pendrin, a novel transcriptional target of the uroguanylin system.

Authors:  Julia Rozenfeld; Osnat Tal; Orly Kladnitsky; Lior Adler; Edna Efrati; Stephen L Carrithers; Seth L Alper; Israel Zelikovic
Journal:  Cell Physiol Biochem       Date:  2013-12-18

6.  Modification of renal and tissue cation transport by cholecystokinin octapeptide in the rabbit.

Authors:  K A Duggan; G Hams; G J MacDonald
Journal:  J Physiol       Date:  1988-03       Impact factor: 5.182

7.  Circulating prouroguanylin is processed to its active natriuretic form exclusively within the renal tubules.

Authors:  Xun Qian; Nicholas G Moss; Robert C Fellner; Michael F Goy
Journal:  Endocrinology       Date:  2008-05-22       Impact factor: 4.736

8.  Uroguanylin, an intestinal natriuretic peptide, is delivered to the kidney as an unprocessed propeptide.

Authors:  Nicholas G Moss; Robert C Fellner; Xun Qian; Sharon J Yu; Zhiping Li; Masamitsu Nakazato; Michael F Goy
Journal:  Endocrinology       Date:  2008-05-22       Impact factor: 4.736

9.  Sodium depletion decreases hepatic metabolism of vasoactive intestinal peptide in the rabbit.

Authors:  K A Duggan; C M Hawley; G J Macdonald; S Shelley
Journal:  J Physiol       Date:  1989-11       Impact factor: 5.182

10.  Impaired renal response to portal infusion of hypertonic saline in adriamycin-treated rats.

Authors:  Dusit Jirakulsomchok; Supitcha Napawachirahat; Narupon Kunbootsri; Tunda Suttitum; Panakaporn Wannanon; James Michael Wyss; Sanya Roysommuti
Journal:  Clin Exp Pharmacol Physiol       Date:  2012-07       Impact factor: 2.557

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.